ICONIC: Improving Carpediem Outcomes in Neonates and Infants Through Collaboration
Sponsored by Children's Hospital Medical Center, Cincinnati
About this trial
Last updated 3 years ago
Study ID
CIN001 - ICONIC
Status
Enrolling by invitation
Type
Observational [Patient Registry]
Placebo
No
Accepting
All
All
Not accepting
Healthy Volunteers
Trial Timing
Started 4 years ago
What is this trial about?
To date, little knowledge exists related to the use of hemodialysis (HD) in infants and has
been limited to mainly single center studies. The CARPEDIEM (CArdio-Renal PEdiatric Dialysis
Emergency Machine) device, which can be used to provide hemodialysis in infants, has been
launched in the United States. This study/registry is designed to obtain data on critically
ill infants who require HD using the CARPEDIEM device to understand the indications for
initiation, best practice in prescribing and performing treatment, expected treatment course,
and outcomes of a dedicated infant continuous renal replacement therapy (CRRT) machine.
What are the participation requirements?
Inclusion Criteria
- Treated with CARPEDIEM as part of standard of care at a participating institution within the United States
Exclusion Criteria
- Parents/legally authorized representative unable or unwilling to provide consent